Higher baseline uric acid concentration is associated with non-attainment of optimal blood pressure

Yuji Sato1, Shouichi Fujimoto2,3, Kunitoshi Iseki3

  • 1Division of Nephrology, Department of Internal Medicine, National Health Insurance Takachiho Town Hospital, Takachiho, Miyazaki, Japan.

Plos One
|July 28, 2020
PubMed

Insights

Higher baseline uric acid levels are linked to poorer blood pressure control in individuals starting antihypertensive drugs. This suggests elevated uric acid may predict treatment challenges for hypertension management.

Area of Science:

  • Cardiology
  • Nephrology
  • Metabolic Disorders

Background:

  • Elevated uric acid is linked to hypertension prevalence and incidence.
  • Limited data exists on uric acid's impact on antihypertensive drug efficacy.
  • Understanding this relationship is crucial for effective hypertension management.

Purpose of the Study:

  • To investigate the association between baseline uric acid concentration and the non-attainment of optimal blood pressure (NOBP) in individuals initiating antihypertensive therapy.
  • To assess if higher uric acid levels predict suboptimal blood pressure control under medication.

Main Methods:

  • Prospective cohort study of 8,664 Japanese adults (mean age 65.5 years).
  • Participants initiated antihypertensive drugs after baseline health check-up.
  • Blood pressure control (NOBP) was assessed, and participants were stratified by baseline uric acid quartiles.

Main Results:

  • The highest quartile of baseline uric acid was significantly associated with NOBP (OR 1.36; 95% CI 1.16-1.59).
  • This association remained significant after adjusting for confounders like age, sex, BMI, diabetes, dyslipidemia, CKD, cardiovascular disease history, alcohol, and smoking.
  • Subgroup analyses in women, and those with diabetes and CKD, showed a significant link between +1 mg/dL of uric acid and NOBP.

Conclusions:

  • Higher baseline uric acid concentration is a significant predictor of suboptimal blood pressure control upon initiation of antihypertensive drug therapy.
  • Elevated uric acid may indicate a poorer response to standard antihypertensive treatments.
  • Further research is warranted to explore mechanisms and therapeutic strategies targeting uric acid in hypertension management.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
260
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
2.0K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
346
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
412
Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
958